BioPorto 是一家體外診斷公司，為世界各地的臨床醫(yī)生和研究人員提供測試和抗體。我們利用我們的抗體和檢測專業(yè)知識將新的研究工具轉(zhuǎn)化為臨床上可操作的生物標(biāo)志物，從而改變患者的生活。BioPorto 總部位于丹麥海勒魯普，美國總部位于馬薩諸塞州尼德姆，并在納斯達克哥本哈根證券交易所上市。
bioporto2022年價格表
| 貨號 | 品名 | 規(guī)格 | 價格 | 品牌 |
| ABS 001-07-04 | APC–AAT complexes, neoepitope (human) | 400µl | 16135.2 | bioporto |
| ABS 001-07-1 | APC–AAT complexes, neoepitope (human) | 1ml | 37033.2 | bioporto |
| ABS 002-09-04 | Complement component C1s (human, pro- and activated enzyme) | 400µl | 16135.2 | bioporto |
| ABS 002-09-1 | Complement component C1s (human, pro- and activated enzyme) | 1ml | 37033.2 | bioporto |
| ABS 002-49-04 | Complement component C1s (human, pro- and activated enzyme) | 400µl | 16135.2 | bioporto |
| ABS 002-49-1 | Complement component C1s (human, pro- and activated enzyme) | 1ml | 37033.2 | bioporto |
| ABS 004-22-04 | Complement component C9 (human) | 400µl | 16135.2 | bioporto |
| ABS 004-22-1 | Complement component C9 (human) | 1ml | 37033.2 | bioporto |
| ABS 004-53-04 | Complement component C9 (human) | 400µl | 16135.2 | bioporto |
| ABS 004-53-1 | Complement component C9 (human) | 1ml | 37033.2 | bioporto |
| ABS 005-16-04 | L-Ficolin (human) | 400µl | 16135.2 | bioporto |
| ABS 005-16-1 | L-Ficolin (human) | 1ml | 37033.2 | bioporto |
| ABS 005-19-04 | L-Ficolin (human) | 400µl | 16135.2 | bioporto |
| ABS 005-19-1 | L-Ficolin (human) | 1ml | 37033.2 | bioporto |
| ABS 006-01-04 | Pregnancy-associated plasma protein A (human, PAPP-A) | 400µl | 16135.2 | bioporto |
| ABS 006-01-1 | Pregnancy-associated plasma protein A (human, PAPP-A) | 1ml | 37033.2 | bioporto |
| ABS 006-24-04 | Pregnancy-associated plasma protein A (human, PAPP-A) | 400µl | 16135.2 | bioporto |
| ABS 006-24-1 | Pregnancy-associated plasma protein A (human, PAPP-A) | 1ml | 37033.2 | bioporto |
| ABS 012-20-04 | Exendin-4 | 400µl | 23814 | bioporto |
| ABS 012-20-1 | Exendin-4 | 1ml | 53168.4 | bioporto |
| ABS 012-24-04 | Exendin-4 | 400µl | 23814 | bioporto |
| ABS 012-24-1 | Exendin-4 | 1ml | 53168.4 | bioporto |
| ABS 012-35-04 | Exendin-4 | 400µl | 23814 | bioporto |
| ABS 012-35-1 | Exendin-4 | 1ml | 53168.4 | bioporto |
| ABS 012-35B-015 | Exendin-4 | 150µl | 26924.4 | bioporto |
| ABS 013-04-04 | Hemopexin (human) | 400µl | 16135.2 | bioporto |
| ABS 013-04-1 | Hemopexin (human) | 1ml | 37033.2 | bioporto |
| ABS 013-04B-015 | Hemopexin (human) | 150µl | 18565.2 | bioporto |
| ABS 013-32-04 | Hemopexin (human) | 400µl | 16135.2 | bioporto |
| ABS 013-32-1 | Hemopexin (human) | 1ml | 37033.2 | bioporto |
| ABS 013-32B-015 | Hemopexin (human) | 150µl | 18565.2 | bioporto |
| ABS 014-22-04 | TAT (Thrombin-antithrombin) | 400µl | 23814 | bioporto |
| ABS 014-22-1 | TAT (Thrombin-antithrombin) | 1ml | 53168.4 | bioporto |
| ABS 015-22-04 | D-dimer (human, dog) | 400µl | 16135.2 | bioporto |
| ABS 015-22-1 | D-dimer (human, dog) | 1ml | 37033.2 | bioporto |
| ABS 015-22B-015 | D-dimer (human, dog) | 150µl | 18565.2 | bioporto |
| ABS 015-28-04 | D-dimer (human, dog) | 400µl | 16135.2 | bioporto |
| ABS 015-28-1 | D-dimer (human, dog) | 1ml | 37033.2 | bioporto |
| ABS 017-20-04 | Gelsolin (human) | 400µl | 21578.4 | bioporto |
| ABS 017-20-1 | Gelsolin (human) | 1ml | 48697.2 | bioporto |
| ABS 020-03-04 | Peptide Histidine-Methionine (human, PHM) | 400µl | 16135.2 | bioporto |
| ABS 020-03-1 | Peptide Histidine-Methionine (human, PHM) | 1ml | 37033.2 | bioporto |
| ABS 021-04-04 | Gastric Inhibitory Polypeptide (GIP) | 400µl | 23814 | bioporto |
| ABS 021-04-1 | Gastric Inhibitory Polypeptide (GIP) | 1ml | 53168.4 | bioporto |
| ABS 022-03-04 | Leptin | 400µl | 16135.2 | bioporto |
| ABS 022-03-1 | Leptin | 1ml | 37033.2 | bioporto |
| ABS 022-06-04 | Leptin | 400µl | 16135.2 | bioporto |
| ABS 022-06-1 | Leptin | 1ml | 37033.2 | bioporto |
| ABS 022-11-04 | Leptin | 400µl | 16135.2 | bioporto |
| ABS 022-11-1 | Leptin | 1ml | 37033.2 | bioporto |
| ABS 022-11B-015 | Leptin | 150µl | 18565.2 | bioporto |
| ABS 023-02-04 | Vasoactive Intestinal Peptide (human, bovine, porcine, rat, VIP) | 400µl | 21578.4 | bioporto |
| ABS 023-02-1 | Vasoactive Intestinal Peptide (human, bovine, porcine, rat, VIP) | 1ml | 48697.2 | bioporto |
| ABS 026-04-04 | alpha-calcitonin gene-related peptide (alpha-CGRP) | 400µl | 21578.4 | bioporto |
| ABS 026-04-1 | alpha-calcitonin gene-related peptide (alpha-CGRP) | 1ml | 48697.2 | bioporto |
| ABS 026-05-04 | alpha-calcitonin gene-related peptide (alpha-CGRP) | 400µl | 21578.4 | bioporto |
| ABS 026-05-1 | alpha-calcitonin gene-related peptide (alpha-CGRP) | 1ml | 48697.2 | bioporto |
| ABS 027-01-04 | Adrenomedullin (human) | 400µl | 23814 | bioporto |
| ABS 027-01-1 | Adrenomedullin (human) | 1ml | 53168.4 | bioporto |
| ABS 028-08-04 | Neuropeptide Y (human, rat, mouse, NPY) | 400µl | 21578.4 | bioporto |
| ABS 028-08-1 | Neuropeptide Y (human, rat, mouse, NPY) | 1ml | 48697.2 | bioporto |
| ABS 029-01-04 | Peptide YY (human, PYY) | 400µl | 23814 | bioporto |
| ABS 029-01-1 | Peptide YY (human, PYY) | 1ml | 53168.4 | bioporto |
| ABS 029-01B-015 | Peptide YY (human, PYY) | 150µl | 26924.4 | bioporto |
| ABS 030-06-04 | Pancreatic Polypeptide (human, PP) | 400µl | 16135.2 | bioporto |
| ABS 030-06-1 | Pancreatic Polypeptide (human, PP) | 1ml | 37033.2 | bioporto |
| ABS 033-04-04 | Glucagon-like peptide-1 (GLP-1(7-37) and GLP-1(7-36)amide, N-terminal specific) | 400µl | 23814 | bioporto |
| ABS 033-04-1 | Glucagon-like peptide-1 (GLP-1(7-37) and GLP-1(7-36)amide, N-terminal specific) | 1ml | 53168.4 | bioporto |
| ABS 033-10-04 | Glucagon-like peptide-1 (GLP-1(7-37) and GLP-1(7-36)amide, N-terminal specific) | 400µl | 23814 | bioporto |
| ABS 033-10-1 | Glucagon-like peptide-1 (GLP-1(7-37) and GLP-1(7-36)amide, N-terminal specific) | 1ml | 53168.4 | bioporto |
| ABS 033-10B-015 | Glucagon-like peptide-1 (GLP-1(7-37) and GLP-1(7-36)amide, N-terminal specific) | 150µl | 26924.4 | bioporto |
| ABS 036-01-04 | M-Ficolin (human) | 400µl | 16135.2 | bioporto |
| ABS 036-01-1 | M-Ficolin (human) | 1ml | 37033.2 | bioporto |
| ABS 036-05-04 | M-Ficolin (human) | 400µl | 16135.2 | bioporto |
| ABS 036-05-1 | M-Ficolin (human) | 1ml | 37033.2 | bioporto |
| ABS 037-18-04 | Aprotinin | 400µl | 23814 | bioporto |
| ABS 037-18-1 | Aprotinin | 1ml | 53168.4 | bioporto |
| ABS 037-18B-015 | Aprotinin | 150µl | 26924.4 | bioporto |
| ABS 037-21-04 | Aprotinin | 400µl | 23814 | bioporto |
| ABS 037-21-1 | Aprotinin | 1ml | 53168.4 | bioporto |
| ABS 037-35-04 | Aprotinin | 400µl | 23814 | bioporto |
| ABS 037-35-1 | Aprotinin | 1ml | 53168.4 | bioporto |
| ABS 038-04-04 | Neutrophil gelatinase-associated lipocalin (human, NGAL) | 400µl | 23814 | bioporto |
| ABS 038-04-1 | Neutrophil gelatinase-associated lipocalin (human, NGAL) | 1ml | 53168.4 | bioporto |
| ABS 038-14-04 | Neutrophil gelatinase-associated lipocalin (human, NGAL) | 400µl | 23814 | bioporto |
| ABS 038-14-1 | Neutrophil gelatinase-associated lipocalin (human, NGAL) | 1ml | 53168.4 | bioporto |
| ABS 038-14B-015 | Neutrophil gelatinase-associated lipocalin (human, NGAL) | 150µl | 26924.4 | bioporto |
| ABS 038-15-04 | Neutrophil gelatinase-associated lipocalin (human, NGAL) | 400µl | 23814 | bioporto |
| ABS 038-15-1 | Neutrophil gelatinase-associated lipocalin (human, NGAL) | 1ml | 53168.4 | bioporto |
| ABS 038-15B-015 | Neutrophil gelatinase-associated lipocalin (human, NGAL) | 150µl | 26924.4 | bioporto |
| ABS 038-26-04 | Neutrophil gelatinase-associated lipocalin (human, NGAL) | 400µl | 23814 | bioporto |
| ABS 038-26-1 | Neutrophil gelatinase-associated lipocalin (human, NGAL) | 1ml | 53168.4 | bioporto |
| ABS 039-08-04 | Neutrophil gelatinase-associated lipocalin (rat, NGAL) | 400µl | 23814 | bioporto |
| ABS 039-08-1 | Neutrophil gelatinase-associated lipocalin (rat, NGAL) | 1ml | 53168.4 | bioporto |
| ABS 039-15-04 | Neutrophil gelatinase-associated lipocalin (rat, NGAL) | 400µl | 23814 | bioporto |
| ABS 039-15-1 | Neutrophil gelatinase-associated lipocalin (rat, NGAL) | 1ml | 53168.4 | bioporto |
| ABS 039-32-04 | Neutrophil gelatinase-associated lipocalin (rat, NGAL) | 400µl | 23814 | bioporto |
| ABS 039-32-1 | Neutrophil gelatinase-associated lipocalin (rat, NGAL) | 1ml | 53168.4 | bioporto |
| ABS 039-32B-015 | Neutrophil gelatinase-associated lipocalin (rat, NGAL) | 150µl | 26924.4 | bioporto |
| ABS 043-10-04 | Neutrophil gelatinase-associated lipocalin (mouse, NGAL) | 400µl | 23814 | bioporto |
| ABS 043-10-1 | Neutrophil gelatinase-associated lipocalin (mouse, NGAL) | 1ml | 53168.4 | bioporto |
| ABS 043-29-04 | Neutrophil gelatinase-associated lipocalin (mouse, NGAL) | 400µl | 23814 | bioporto |
| ABS 043-29-1 | Neutrophil gelatinase-associated lipocalin (mouse, NGAL) | 1ml | 53168.4 | bioporto |
| ABS 043-29B-015 | Neutrophil gelatinase-associated lipocalin (mouse, NGAL) | 150µl | 26924.4 | bioporto |
| ABS 044-49-04 | Glucagon-like peptide-1 (GLP-1(9-37) and GLP-1(9-36)amide, N-terminal specific) | 400µl | 23814 | bioporto |
| ABS 044-49-1 | Glucagon-like peptide-1 (GLP-1(9-37) and GLP-1(9-36)amide, N-terminal specific) | 1ml | 53168.4 | bioporto |
| ABS 044-53-04 | Glucagon-like peptide-1 (GLP-1(9-37) and GLP-1(9-36)amide, N-terminal specific) | 400µl | 23814 | bioporto |
| ABS 044-53-1 | Glucagon-like peptide-1 (GLP-1(9-37) and GLP-1(9-36)amide, N-terminal specific) | 1ml | 53168.4 | bioporto |
| ABS 046-03-04 | Glucagon-like peptide-1 (GLP-1, Non-amidated (-Arg-Gly), C-terminal specific) | 400µl | 23814 | bioporto |
| ABS 046-03-1 | Glucagon-like peptide-1 (GLP-1, Non-amidated (-Arg-Gly), C-terminal specific) | 1ml | 53168.4 | bioporto |
| ABS 046-03B-015 | Glucagon-like peptide-1 (GLP-1, Non-amidated (-Arg-Gly), C-terminal specific) | 150µl | 26924.4 | bioporto |
| ABS 047-14-04 | Neutrophil gelatinase-associated lipocalin (dog, NGAL) | 400µl | 23814 | bioporto |
| ABS 047-14-1 | Neutrophil gelatinase-associated lipocalin (dog, NGAL) | 1ml | 53168.4 | bioporto |
| ABS 047-14B-015 | Neutrophil gelatinase-associated lipocalin (dog, NGAL) | 150µl | 26924.4 | bioporto |
| ABS 047-17-04 | Neutrophil gelatinase-associated lipocalin (dog, NGAL) | 400µl | 23814 | bioporto |
| ABS 047-17-1 | Neutrophil gelatinase-associated lipocalin (dog, NGAL) | 1ml | 53168.4 | bioporto |
| ABS 048-17-04 | Neutrophil gelatinase-associated lipocalin (pig, NGAL) | 400µl | 23814 | bioporto |
| ABS 048-17-1 | Neutrophil gelatinase-associated lipocalin (pig, NGAL) | 1ml | 53168.4 | bioporto |
| ABS 048-28-04 | Neutrophil gelatinase-associated lipocalin (pig, NGAL) | 400µl | 23814 | bioporto |
| ABS 048-28-1 | Neutrophil gelatinase-associated lipocalin (pig, NGAL) | 1ml | 53168.4 | bioporto |
| ABS 048-28B-015 | Neutrophil gelatinase-associated lipocalin (pig, NGAL) | 150µl | 26924.4 | bioporto |
| ABS 050-45-04 | Ghrelin (human) | 400µl | 23814 | bioporto |
| ABS 050-45-1 | Ghrelin (human) | 1ml | 53168.4 | bioporto |
| ABS 051-04-04 | PYY (3-36)(peptide tyrosine-tyrosine amide, 3-36) | 400µl | 23814 | bioporto |
| ABS 051-04-1 | PYY (3-36)(peptide tyrosine-tyrosine amide, 3-36) | 1ml | 53168.4 | bioporto |
| ABS 052-121-04 | Ghrelin (human, rat) | 400µl | 23814 | bioporto |
| ABS 052-121-1 | Ghrelin (human, rat) | 1ml | 53168.4 | bioporto |
| ABS 052-121B-015 | Ghrelin (human, rat) | 150µl | 26924.4 | bioporto |
| ABS 054-14-04 | Anti-Gastric Inhibitory Peptide (3-42)(GIP (3-42)) Mouse monoclonal antibody | 400µl | 23814 | bioporto |
| ABS 054-14-1 | Anti-Gastric Inhibitory Peptide (3-42)(GIP (3-42)) Mouse monoclonal antibody | 1ml | 53168.4 | bioporto |
| ABS 054-14B-015 | Anti-Gastric Inhibitory Peptide (3-42)(GIP (3-42)) Mouse monoclonal antibody, biotinylated | 150µl | 26924.4 | bioporto |
| ABS 054-24-04 | Anti-Gastric Inhibitory Peptide (GIP) Mouse monoclonal antibody | 400µl | 23814 | bioporto |
| ABS 054-24-1 | Anti-Gastric Inhibitory Peptide (GIP) Mouse monoclonal antibody | 1ml | 53168.4 | bioporto |
| ABS 054-24B-015 | Anti-Gastric Inhibitory Peptide (GIP) Mouse monoclonal antibody, biotinylated | 150µl | 26924.4 | bioporto |
| ABS 054-26-04 | Anti-Gastric Inhibitory Peptide (GIP) Mouse monoclonal antibody | 400µl | 23814 | bioporto |
| ABS 054-26-1 | Anti-Gastric Inhibitory Peptide (GIP) Mouse monoclonal antibody | 1ml | 53168.4 | bioporto |
| ABS 057-25-04 | Anti-Gastric Inhibitory Peptide (3-42) (GIP (3-42)) Mouse monoclonal antibody | 400µl | 23814 | bioporto |
| ABS 057-25-1 | Anti-Gastric Inhibitory Peptide (3-42) (GIP (3-42)) Mouse monoclonal antibody | 1ml | 53168.4 | bioporto |
| ABS 058-08-04 | Glucagon (human, pig, rat) | 400µl | 23814 | bioporto |
| ABS 058-08-1 | Glucagon (human, pig, rat) | 1ml | 53168.4 | bioporto |
| ABS 058-08B-015 | Glucagon (human, pig, rat) | 150µl | 26924.4 | bioporto |
| ABS 059-20-04 | Anti-Oxyntomodulin (human) Mouse Monoclonal Antibody | 400µl | 23814 | bioporto |
| ABS 059-20-1 | Anti-Oxyntomodulin (human) Mouse Monoclonal Antibody | 1ml | 53168.4 | bioporto |
| ABS 059-20B-015 | Anti-Oxyntomodulin (human) Mouse Monoclonal Antibody, Biotinylated | 150µl | 26924.4 | bioporto |
| ABS 061-09-04 | Glucagon (human, pig, rat) | 400µl | 23814 | bioporto |
| ABS 061-09-1 | Glucagon (human, pig, rat) | 1ml | 53168.4 | bioporto |
| ABS 062-14-04 | Neutrophil gelatinase-associated lipocalin (human, NGAL) | 400µl | 23814 | bioporto |
| ABS 062-14-1 | Neutrophil gelatinase-associated lipocalin (human, NGAL) | 1ml | 53168.4 | bioporto |
| ABS 062-14B-015 | Neutrophil gelatinase-associated lipocalin (human, NGAL) | 150µl | 26924.4 | bioporto |
| ABS 062-33-04 | Neutrophil gelatinase-associated lipocalin (human, NGAL) | 400µl | 23814 | bioporto |
| ABS 062-33-1 | Neutrophil gelatinase-associated lipocalin (human, NGAL) | 1ml | 53168.4 | bioporto |
| ABS 063-56-04 | Neutrophil gelatinase-associated lipocalin (monkey, NGAL) | 400µl | 23814 | bioporto |
| ABS 063-56-1 | Neutrophil gelatinase-associated lipocalin (monkey, NGAL) | 1ml | 53168.4 | bioporto |
| ABS 063-68-04 | Neutrophil gelatinase-associated lipocalin (monkey, NGAL) | 400µl | 23814 | bioporto |
| ABS 063-68-1 | Neutrophil gelatinase-associated lipocalin (monkey, NGAL) | 1ml | 53168.4 | bioporto |
| ABS 063-68B-015 | Neutrophil gelatinase-associated lipocalin (monkey, NGAL) | 150µl | 21870 | bioporto |
| ABS 064-23-04 | Anti-Oxyntomodulin (human) Mouse Monoclonal Antibody | 400µl | 23814 | bioporto |
| ABS 064-23-1 | Anti-Oxyntomodulin (human) Mouse Monoclonal Antibody | 1ml | 53168.4 | bioporto |
| ABS 064-46-04 | Anti-Oxyntomodulin (human) Mouse Monoclonal Antibody | 400µl | 23814 | bioporto |
| ABS 064-46-1 | Anti-Oxyntomodulin (human) Mouse Monoclonal Antibody | 1ml | 53168.4 | bioporto |
| BTE 001-13-04 | Placental protein 14 (human, PP14, glycodelin A) | 400µl | 16135.2 | bioporto |
| BTE 001-13-1 | Placental protein 14 (human, PP14, glycodelin A) | 1ml | 37033.2 | bioporto |
| BTE 001-16-04 | Placental protein 14 (human, PP14, glycodelin A) | 400µl | 16135.2 | bioporto |
| BTE 001-16-1 | Placental protein 14 (human, PP14, glycodelin A) | 1ml | 37033.2 | bioporto |
| BTE 002-04-04 | Procollagen type I C-terminal propeptide (human, PICP) | 400µl | 21578.4 | bioporto |
| BTE 002-04-1 | Procollagen type I C-terminal propeptide (human, PICP) | 1ml | 48697.2 | bioporto |
| BTE 002-08-04 | Procollagen type I C-terminal propeptide (human, PICP) | 400µl | 21578.4 | bioporto |
| BTE 002-08-1 | Procollagen type I C-terminal propeptide (human, PICP) | 1ml | 48697.2 | bioporto |
| BTE 002-18-04 | Procollagen type I C-terminal propeptide (human, PICP) | 400µl | 21578.4 | bioporto |
| BTE 002-18-1 | Procollagen type I C-terminal propeptide (human, PICP) | 1ml | 48697.2 | bioporto |
| BTE 003-02-04 | Procollagen type IIA N-terminal propeptide (human, PIIANP) | 400µl | 21578.4 | bioporto |
| BTE 003-02-1 | Procollagen type IIA N-terminal propeptide (human, PIIANP) | 1ml | 48697.2 | bioporto |
| BTE 004-09-04 | Pregnancy-associated plasma protein A (human, PAPP-A) | 400µl | 16135.2 | bioporto |
| BTE 004-09-1 | Pregnancy-associated plasma protein A (human, PAPP-A) | 1ml | 37033.2 | bioporto |
| CAM 003-07-04 | yENaC (y?subunit epithelial sodium channel) | 400µl | 23814 | bioporto |
| CAM 003-07-1 | yENaC (y?subunit epithelial sodium channel) | 1ml | 53168.4 | bioporto |
| CAM 005-02-04 | yENaC (y?subunit epithelial sodium channel) | 400µl | 23814 | bioporto |
| CAM 005-02-1 | yENaC (y?subunit epithelial sodium channel) | 1ml | 53168.4 | bioporto |
| CAM 005-02B-015 | yENaC (y?subunit epithelial sodium channel) | 150µl | 26924.4 | bioporto |
| CAM 008-01-04 | Complement component C3 (human) | 400µl | 23814 | bioporto |
| CAM 008-01-1 | Complement component C3 (human) | 1ml | 53168.4 | bioporto |
| CAM 011-05-04 | Factor XII (human, heavy chain) | 400µl | 23814 | bioporto |
| CAM 011-05-1 | Factor XII (human, heavy chain) | 1ml | 53168.4 | bioporto |
| CAM 011-05B-015 | Factor XII (human, heavy chain) | 150µl | 26924.4 | bioporto |
| CAM 011-37-04 | Factor XII (human, heavy chain) | 400µl | 23814 | bioporto |
| CAM 011-37-1 | Factor XII (human, heavy chain) | 1ml | 53168.4 | bioporto |
| CAM 035-01-04 | yENaC (y?subunit epithelial sodium channel, neoepitope) | 400µl | 23814 | bioporto |
| CAM 035-01-1 | yENaC (y?subunit epithelial sodium channel, neoepitope) | 1ml | 53168.4 | bioporto |
| CAM 072-18-04 | Complement C4c | 400µl | 23814 | bioporto |
| CAM 072-18-1 | Complement C4c | 1ml | 53168.4 | bioporto |
| CSI 001-71-04 | Perlecan (bovine) | 400µl | 21578.4 | bioporto |
| CSI 001-71-1 | Perlecan (bovine) | 1ml | 48697.2 | bioporto |
| CSI 001-74-04 | Perlecan (bovine) | 400µl | 21578.4 | bioporto |
| CSI 001-74-1 | Perlecan (bovine) | 1ml | 48697.2 | bioporto |
| CSI 001-76-04 | Perlecan (bovine) | 400µl | 21578.4 | bioporto |
| CSI 001-76-1 | Perlecan (bovine) | 1ml | 48697.2 | bioporto |
| CSI 002-65-04 | Thrombospondin I (bovine) | 400µl | 23814 | bioporto |
| CSI 002-65-1 | Thrombospondin I (bovine) | 1ml | 53168.4 | bioporto |
| CSI 003-02-04 | Vitronectin (human) | 400µl | 16135.2 | bioporto |
| CSI 003-02-1 | Vitronectin (human) | 1ml | 37033.2 | bioporto |
| CSI 003-23-04 | Vitronectin (human) | 400µl | 16135.2 | bioporto |
| CSI 003-23-1 | Vitronectin (human) | 1ml | 37033.2 | bioporto |
| CSI 004-18-04 | Vitronectin (bovine, horse, rabbit) | 400µl | 21578.4 | bioporto |
| CSI 004-18-1 | Vitronectin (bovine, horse, rabbit) | 1ml | 48697.2 | bioporto |
| CSI 004-27-04 | Vitronectin (bovine, sheep) | 400µl | 21578.4 | bioporto |
| CSI 004-27-1 | Vitronectin (bovine, sheep) | 1ml | 48697.2 | bioporto |
| CSI 005-17-04 | Fibronectin (bovine, human, chicken) | 400µl | 16135.2 | bioporto |
| CSI 005-17-1 | Fibronectin (bovine, human, chicken) | 1ml | 37033.2 | bioporto |
| CSI 005-22-04 | Fibronectin (bovine) | 400µl | 16135.2 | bioporto |
| CSI 005-22-1 | Fibronectin (bovine) | 1ml | 37033.2 | bioporto |
| CSI 005-32-04 | Fibronectin (bovine, human) | 400µl | 16135.2 | bioporto |
| CSI 005-32-1 | Fibronectin (bovine, human) | 1ml | 37033.2 | bioporto |
| CSI 006-01-04 | Collagen Type V (human, dog, sheep, pig, kangaroo, rabbit, bovine) | 400µl | 16135.2 | bioporto |
| CSI 006-01-1 | Collagen Type V (human, dog, sheep, pig, kangaroo, rabbit, bovine) | 1ml | 37033.2 | bioporto |
| CSI 007-01-04 | Collagen Type III (human, dog, rat, kangaroo) | 400µl | 16135.2 | bioporto |
| CSI 007-01-1 | Collagen Type III (human, dog, rat, kangaroo) | 1ml | 37033.2 | bioporto |
| DIA 011-01-04 | Complement component C5b-9 | 400µl | 21578.4 | bioporto |
| DIA 011-01-1 | Complement component C5b-9 | 1ml | 48697.2 | bioporto |
| DIA 011-01B-015 | Complement component C5b-9 | 150µl | 18565.2 | bioporto |
| FIA 028-31-04 | Avian Flu F28-AIH7N1 | 400µl | 23814 | bioporto |
| FIA 028-31-1 | Avian Flu F28-AIH7N1 | 1ml | 53168.4 | bioporto |
| FIA 028-73-04 | Avian Flu F28 | 400µl | 23814 | bioporto |
| FIA 028-73-1 | Avian Flu F28 | 1ml | 53168.4 | bioporto |
| FIA 039-09-04 | Avian Flu F39-AIH7N1 | 400µl | 23814 | bioporto |
| FIA 039-09-1 | Avian Flu F39-AIH7N1 | 1ml | 53168.4 | bioporto |
| FIA 039-16-04 | Avian Flu F39-AIH7N1 | 400µl | 23814 | bioporto |
| FIA 039-16-1 | Avian Flu F39-AIH7N1 | 1ml | 53168.4 | bioporto |
| FIA 039-16B-015 | Avian Flu F39-AIH7N1 | 150µl | 26924.4 | bioporto |
| GAU 008-01-04 | Complement factor D (human) | 400µl | 16135.2 | bioporto |
| GAU 008-01-1 | Complement factor D (human) | 1ml | 37033.2 | bioporto |
| GAU 008-01B-015 | Complement factor D (human) | 150µl | 18565.2 | bioporto |
| GAU 010-04-04 | Complement factor D (human) | 400µl | 16135.2 | bioporto |
| GAU 010-04-1 | Complement factor D (human) | 1ml | 37033.2 | bioporto |
| GAU 013-16-04 | Complement component C3a/C3a(desArg)/C3 (human) | 400µl | 16135.2 | bioporto |
| GAU 013-16-1 | Complement component C3a/C3a(desArg)/C3 (human) | 1ml | 37033.2 | bioporto |
| GAU 017-01-04 | Complement component C3a/C3a(desArg)/C3 (human) | 400µl | 16135.2 | bioporto |
| GAU 017-01-1 | Complement component C3a/C3a(desArg)/C3 (human) | 1ml | 37033.2 | bioporto |
| GAU 017-01B-015 | Complement component C3a/C3a(desArg)/C3 (human) | 150µl | 18565.2 | bioporto |
| GAU 018-03-04 | Complement factor H (human, ?1H-globulin) | 400µl | 16135.2 | bioporto |
| GAU 018-03-1 | Complement factor H (human, ?1H-globulin) | 1ml | 37033.2 | bioporto |
| GAU 020-03-04 | Complement factor H (human, ?1H-globulin) | 400µl | 16135.2 | bioporto |
| GAU 020-03-1 | Complement factor H (human, ?1H-globulin) | 1ml | 37033.2 | bioporto |
| GAU 020-03B-015 | Complement factor H (human, ?1H-globulin) | 150µl | 18565.2 | bioporto |
| GAU 025-05-04 | Anti-Complement component C5a/C5a(desArg) anaphylatoxin (human) | 400µl | 23814 | bioporto |
| GAU 025-05-1 | Anti-Complement component C5a/C5a(desArg) anaphylatoxin (human) | 1ml | 53168.4 | bioporto |
| JST 001-38-04 | APC-PCI Complex specific antibody | 400µl | 23814 | bioporto |
| JST 001-38-1 | APC-PCI Complex specific antibody | 1ml | 53168.4 | bioporto |
| KSK 003-01-04 | beta2-Microglobulin (caiman) | 400µl | 16135.2 | bioporto |
| KSK 003-01-1 | beta2-Microglobulin (caiman) | 1ml | 37033.2 | bioporto |
| MON I-1-04 | Plasminogen activator inhibitor type I (human, PAI-1) | 400µl | 16135.2 | bioporto |
| MON I-1-1 | Plasminogen activator inhibitor type I (human, PAI-1) | 1ml | 37033.2 | bioporto |
| MON I-2-04 | Plasminogen activator inhibitor type I (human, PAI-1) | 400µl | 16135.2 | bioporto |
| MON I-2-1 | Plasminogen activator inhibitor type I (human, PAI-1) | 1ml | 37033.2 | bioporto |
| MON I-3-04 | Plasminogen activator inhibitor type I (human, PAI-1) | 400µl | 16135.2 | bioporto |
| MON I-3-1 | Plasminogen activator inhibitor type I (human, PAI-1) | 1ml | 37033.2 | bioporto |
| MON I-5-04 | Plasminogen activator inhibitor type I (human, PAI-1) | 400µl | 16135.2 | bioporto |
| MON I-5-1 | Plasminogen activator inhibitor type I (human, PAI-1) | 1ml | 37033.2 | bioporto |
| MON I-6-04 | Plasminogen activator inhibitor type I (human, PAI-1) | 400µl | 16135.2 | bioporto |
| MON I-6-1 | Plasminogen activator inhibitor type I (human, PAI-1) | 1ml | 37033.2 | bioporto |
| MON R-4-04 | Urokinase plasminogen activator receptor (human, uPAR) | 400µl | 16135.2 | bioporto |
| MON R-4-1 | Urokinase plasminogen activator receptor (human, uPAR) | 1ml | 37033.2 | bioporto |
| MON U-12-04 | Urokinase plasminogen activator (human, uPA) | 400µl | 16135.2 | bioporto |
| MON U-12-1 | Urokinase plasminogen activator (human, uPA) | 1ml | 37033.2 | bioporto |
| MON U-16-04 | Urokinase plasminogen activator (human, uPA) | 400µl | 16135.2 | bioporto |
| MON U-16-1 | Urokinase plasminogen activator (human, uPA) | 1ml | 37033.2 | bioporto |
| MON U-5-04 | Urokinase plasminogen activator (human, uPA) | 400µl | 16135.2 | bioporto |
| MON U-5-1 | Urokinase plasminogen activator (human, uPA) | 1ml | 37033.2 | bioporto |
| MON U-6-04 | Urokinase plasminogen activator (human, uPA) | 400µl | 16135.2 | bioporto |
| MON U-6-1 | Urokinase plasminogen activator (human, uPA) | 1ml | 37033.2 | bioporto |
| RIG 334-01-04 | Ficolin H (human) | 400µl | 23814 | bioporto |
| RIG 334-01-1 | Ficolin H (human) | 1ml | 53168.4 | bioporto |
| RIG 334-01B-015 | Ficolin H (human) | 150µl | 21870 | bioporto |
| HYB 213-06-04 | Glycoprotein-340 (human, gp-340) | 400µl | 20169 | bioporto |
| HYB 213-06-1 | Glycoprotein-340 (human, gp-340) | 1ml | 46291.5 | bioporto |
| HYB 238-04-04 | Surfactant protein A (human, hSP-A) | 400µl | 20169 | bioporto |
| HYB 238-04-1 | Surfactant protein A (human, hSP-A) | 1ml | 46291.5 | bioporto |
| HYB 238-04B-015 | Surfactant protein A (human, hSP-A) | 150µl | 23206.5 | bioporto |
| HYB 245-01-04 | Surfactant protein D (human, hSP-D) | 400µl | 20169 | bioporto |
| HYB 245-01-1 | Surfactant protein D (human, hSP-D) | 1ml | 46291.5 | bioporto |
| HYB 245-02-04 | Surfactant protein D (human, hSP-D) | 400µl | 19197 | bioporto |
| HYB 245-02-1 | Surfactant protein D (human, hSP-D) | 1ml | 46291.5 | bioporto |
| HYB 246-04-04 | Surfactant protein D (human, hSP-D) | 400µl | 20169 | bioporto |
| HYB 246-04-1 | Surfactant protein D (human, hSP-D) | 1ml | 46291.5 | bioporto |
| HYB 246-04B-015 | Surfactant protein D (human, hSP-D) | 150µl | 23206.5 | bioporto |
| DIA HE1-04 | Human IgE (non-immune), without azide | 400µl | 26924.4 | bioporto |
| DIA HE1-1 | Human IgE (non-immune), without azide | 1mL | 29646 | bioporto |
| DIA HE1A-04 | Human IgE (non-immune), with azide | 400µl | 26924.4 | bioporto |
| DIA HE1A-1 | Human IgE (non-immune), with azide | 1mL | 29646 | bioporto |
| DIA HE1B-015 | Human IgE (non-immune) Biotinylated | 150µl | 12733.2 | bioporto |
| KIT 036 | NGAL ELISA Kit | 96well | 11469.6 | bioporto |
| KIT 042 | Mouse NGAL ELISA Kit | 96well | 10400.4 | bioporto |
| KIT 043 | Dog NGAL ELISA Kit | 96well | 12636 | bioporto |
| KIT 044 | Pig NGAL ELISA Kit | 96well | 12636 | bioporto |
| KIT 045 | Monkey NGAL ELISA Kit | 96well | 23619.6 | bioporto |
| KIT 046 | Rat NGAL ELISA Kit | 96well | 10983.6 | bioporto |
| KIT 049 | Horse NGAL ELISA Kit | 96well | 14288.4 | bioporto |
| SP001RA | Recombinant Human Monomer NGAL | 1mL | 6075 | bioporto |
| SP002RA | Recombinant Mouse NGAL | 1mL | 6075 | bioporto |
| SP003RA | Recombinant Rat NGAL | 1mL | 6075 | bioporto |
| SP004RA | Recombinant Dog NGAL | 1mL | 6075 | bioporto |
| SP005RA | Recombinant Pig NGAL | 1mL | 6075 | bioporto |
| SP006RA | Recombinant Monkey NGAL | 1mL | 6075 | bioporto |
| ST001RA | The NGAL Test™ Reagent Kit | ea | 31881.6 | bioporto |
| ST002RA | The NGAL Test™ Calibrator Kit | ea | 3596.4 | bioporto |
| ST003RA | The NGAL Test™ Control Kit | ea | 7095.6 | bioporto |
